Posted On: 07/01/2014 6:08:59 AM
Post# of 273350
Johnson & Johnson (JNJ) 104.62 $JNJ
Global Ophthalmology Devices Market Report - Competitive Landscape & Forecasts to 2018
M2 - 44 mins ago
Research and Markets (http://www.researchandmarkets.com/research/47k8pd/ophthalmology) has announced the addition of the "Ophthalmology Devices Market - Competitive Landscape & Global Forecasts to 2018" report to their offering. The global ophthalmology devices market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and a favorable reimbursement scenario for diagnostic devices in major developed economies. Moreover, incidences of glaucoma and cataract are increasing every year. However, market growth will be inhibited by economic slowdown in the U.S. and Europe, and saturating developed markets. Asian countries like China and India and other developing nations are still naive and pose a great opportunity for companies to invest and grow at double-digit growth rates. The ophthalmology devices market consists of surgical devices which are used in cases of cataract, glaucoma, refractive errors, and vitreoretinal disorders; diagnostic and monitoring devices; and vision care products. The ophthalmic diagnostic and monitoring devices studied in this report primarily focuses on the devices used to diagnose disorders associated with the retina (posterior segment) and the cornea (anterior segment). These devices measure refractive errors, affix lenses, identify the power of IOLs, and analyze the visual field, amongst others. The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest of the world (RoW). North America is the largest market for ophthalmology devices, followed by Europe and Asia. North America and Europe is expected to grow at a slower pace, primarily due to the economic slowdown and saturation in these markets. APAC is an unsaturated market, especially China and India, and these regions are expected to drive the growth of the overall ophthalmology market, mainly due to growing awareness of eye diseases and increasing disposable income. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Pricing Trends 4 Market Overview 5 Global Opthalmology Devices Market, By Product 6 Geographic Analysis 7 Competitive Landscape 8 Company Profiles - Abbott Medical Optics, Inc. (Abbott Laboratories) - Alcon, Inc. (A Novartis Company) - Bausch & Lomb, Inc. - Carl Zeiss Meditec Ag - Essilor International S.A - Haag-Streit Ag - Johnson & Johnson - Nidek Co. Ltd. - Topcon Corporation - Ziemer Ophthalmic Systems Ag For more information visit http://www.researchandmarkets.com/research/47...thalmology
GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection
PR Newswire Europe - Tue Jul 01, 1:00AM CDT
GlycoVaxyn AG, a leader in the development of innovative conjugate vaccines, today announced the initiation of a Phase 1 clinical trial of a candidate vaccine to prevent infections caused by Extra-intestinal Pathogenic Escherichia coli (ExPEC), such as urinary tract infections (UTIs). The investigational vaccine is being co-developed by GlycoVaxyn AG and Janssen Pharmaceuticals Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Predicting Dendreon's Next CEO's Future
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Mon Jun 30, 8:00PM CDT
Investors in Dendreon (Nasdaq: DNDN) are used to bad news, but a change in the CEO suite has given hope new leadership can turn around the struggling prostate cancer vaccine maker. Under his stewardship CEO John Johnson admirably cut costs, but...
Final Glance: Pharmaceuticals companies
AP - Mon Jun 30, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Jun 30, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
3 Reasons Johnson & Johnson Belongs in Your Dividend Portfolio
John Maxfield, The Motley Fool - Motley Fool - Mon Jun 30, 3:46PM CDT
Finding a great dividend stock is easier said than done. Nevertheless, there are a handful of generous-yielding stocks that could be comfortably added to any income investor's portfolio. One such example is Johnson & Johnson , the...
Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group
PR Newswire - Mon Jun 30, 3:30PM CDT
Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion, subject to customary adjustments.
Midday Glance: Pharmaceuticals companies
AP - Mon Jun 30, 12:25PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Jun 30, 12:25PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
5 Rocket Stocks to Buy in July
at The Street - Mon Jun 30, 11:02AM CDT
These stocks have both short-term gain catalysts and longer-term growth potential.
Early Glance: Medical Devices companies
AP - Mon Jun 30, 9:34AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Jun 30, 9:34AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Johnson & Johnson Up 16.8% Since SmarTrend Uptrend Call (JNJ)
Comtex SmarTrend(R) - Mon Jun 30, 9:21AM CDT
SmarTrend identified an Uptrend for Johnson & Johnson (NYSE:JNJ) on February 10th, 2014 at $90.44. In approximately 5 months, Johnson & Johnson has returned 16.84% as of today's recent price of $105.67.
Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Boeing (BA) Lags
at The Street - Mon Jun 30, 9:00AM CDT
The Dow component leading the way higher looks to be Johnson & Johnson (NYSE: JNJ ), which is sporting a 66-cent gain (+0.6%) bringing the stock to $105.65. Holding back the Dow today is Boeing (NYSE: BA ), which is lagging the broader Dow...
Mihalich v. Johnson & Johnson Classified as a Class Action Lawsuit
PRWeb - Mon Jun 30, 7:14AM CDT
The defective products lawyers at Parilman & Associates have been representing injured consumers all over the United States for several years as they have sought legal relief from entities that have provided those clients with dangerous and defective products. As part of their service, the attorneys at the firm work to keep the public informed of legal developments that relate to any product that they may commonly use. As such, Parilman & Associates hereby alerts consumers to the filing of a talcum powder class action lawsuit that has been filed against Johnson & Johnson. The lawsuit alleges that using this product can increase the risk of ovarian cancer.
Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK
PR Newswire - Mon Jun 30, 4:20AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ), AbbVie Inc (NYSE: ABBV), Valeant Pharmaceuticals Intl Inc (NYSE: VRX) and GlaxoSmithKline plc (ADR) (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4237-100free.
World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) 2013-2017
M2 - Mon Jun 30, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4h95wb/the_world_market) has announced the addition of the "The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)" report to their offering. The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) Catheters make it possible to drain or inject fluids or enable access to the body by surgical instruments. In most instances, a catheter is a thin, flexible tube, though there is great diversity in catheter types and applications. This report provides descriptions of the types of catheters and estimates their market size and discusses the competitive activity in each category. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. This is a minimally invasive procedure in which a catheter is guided into the heart, usually through a blood vessel in the leg or arm. Once inside the heart, it can be used for diagnosing or treating a condition. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia. The purpose of the drain is to remove fluid or blood from the surgical site. This helps the healing process. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize on the World Market for Catheters. This report is a comprehensive look at the market of these critical medical devices. Which segments of catheters provide the most opportunity? Which are growing the fastest? Who are the key players and what share do they have of the market? What are the critical issues and trends that will drive catheter sales in the future. What pitfalls do manufacturers need to be aware of? These questions and more are answered in this report. This report contains global market size and forecast to 2017 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters Suction Catheters Wound Drainage Catheters Company profiles are included, with profiles of the following companies: - Abbott - Angio Dynamics - Atrium Medical - Bactiguard AB - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Edwards Lifesciences - Greatbatch Medical - Johnson & Johnson - Hansen Medical - Iapyx Medical - Integra LifeSciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St. Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/4h...rld_market
Global Ophthalmology Devices Market Report - Competitive Landscape & Forecasts to 2018
M2 - 44 mins ago
Research and Markets (http://www.researchandmarkets.com/research/47k8pd/ophthalmology) has announced the addition of the "Ophthalmology Devices Market - Competitive Landscape & Global Forecasts to 2018" report to their offering. The global ophthalmology devices market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and a favorable reimbursement scenario for diagnostic devices in major developed economies. Moreover, incidences of glaucoma and cataract are increasing every year. However, market growth will be inhibited by economic slowdown in the U.S. and Europe, and saturating developed markets. Asian countries like China and India and other developing nations are still naive and pose a great opportunity for companies to invest and grow at double-digit growth rates. The ophthalmology devices market consists of surgical devices which are used in cases of cataract, glaucoma, refractive errors, and vitreoretinal disorders; diagnostic and monitoring devices; and vision care products. The ophthalmic diagnostic and monitoring devices studied in this report primarily focuses on the devices used to diagnose disorders associated with the retina (posterior segment) and the cornea (anterior segment). These devices measure refractive errors, affix lenses, identify the power of IOLs, and analyze the visual field, amongst others. The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest of the world (RoW). North America is the largest market for ophthalmology devices, followed by Europe and Asia. North America and Europe is expected to grow at a slower pace, primarily due to the economic slowdown and saturation in these markets. APAC is an unsaturated market, especially China and India, and these regions are expected to drive the growth of the overall ophthalmology market, mainly due to growing awareness of eye diseases and increasing disposable income. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Pricing Trends 4 Market Overview 5 Global Opthalmology Devices Market, By Product 6 Geographic Analysis 7 Competitive Landscape 8 Company Profiles - Abbott Medical Optics, Inc. (Abbott Laboratories) - Alcon, Inc. (A Novartis Company) - Bausch & Lomb, Inc. - Carl Zeiss Meditec Ag - Essilor International S.A - Haag-Streit Ag - Johnson & Johnson - Nidek Co. Ltd. - Topcon Corporation - Ziemer Ophthalmic Systems Ag For more information visit http://www.researchandmarkets.com/research/47...thalmology
GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection
PR Newswire Europe - Tue Jul 01, 1:00AM CDT
GlycoVaxyn AG, a leader in the development of innovative conjugate vaccines, today announced the initiation of a Phase 1 clinical trial of a candidate vaccine to prevent infections caused by Extra-intestinal Pathogenic Escherichia coli (ExPEC), such as urinary tract infections (UTIs). The investigational vaccine is being co-developed by GlycoVaxyn AG and Janssen Pharmaceuticals Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Predicting Dendreon's Next CEO's Future
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Mon Jun 30, 8:00PM CDT
Investors in Dendreon (Nasdaq: DNDN) are used to bad news, but a change in the CEO suite has given hope new leadership can turn around the struggling prostate cancer vaccine maker. Under his stewardship CEO John Johnson admirably cut costs, but...
Final Glance: Pharmaceuticals companies
AP - Mon Jun 30, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Jun 30, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
3 Reasons Johnson & Johnson Belongs in Your Dividend Portfolio
John Maxfield, The Motley Fool - Motley Fool - Mon Jun 30, 3:46PM CDT
Finding a great dividend stock is easier said than done. Nevertheless, there are a handful of generous-yielding stocks that could be comfortably added to any income investor's portfolio. One such example is Johnson & Johnson , the...
Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group
PR Newswire - Mon Jun 30, 3:30PM CDT
Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion, subject to customary adjustments.
Midday Glance: Pharmaceuticals companies
AP - Mon Jun 30, 12:25PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Jun 30, 12:25PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
5 Rocket Stocks to Buy in July
at The Street - Mon Jun 30, 11:02AM CDT
These stocks have both short-term gain catalysts and longer-term growth potential.
Early Glance: Medical Devices companies
AP - Mon Jun 30, 9:34AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Jun 30, 9:34AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Johnson & Johnson Up 16.8% Since SmarTrend Uptrend Call (JNJ)
Comtex SmarTrend(R) - Mon Jun 30, 9:21AM CDT
SmarTrend identified an Uptrend for Johnson & Johnson (NYSE:JNJ) on February 10th, 2014 at $90.44. In approximately 5 months, Johnson & Johnson has returned 16.84% as of today's recent price of $105.67.
Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Boeing (BA) Lags
at The Street - Mon Jun 30, 9:00AM CDT
The Dow component leading the way higher looks to be Johnson & Johnson (NYSE: JNJ ), which is sporting a 66-cent gain (+0.6%) bringing the stock to $105.65. Holding back the Dow today is Boeing (NYSE: BA ), which is lagging the broader Dow...
Mihalich v. Johnson & Johnson Classified as a Class Action Lawsuit
PRWeb - Mon Jun 30, 7:14AM CDT
The defective products lawyers at Parilman & Associates have been representing injured consumers all over the United States for several years as they have sought legal relief from entities that have provided those clients with dangerous and defective products. As part of their service, the attorneys at the firm work to keep the public informed of legal developments that relate to any product that they may commonly use. As such, Parilman & Associates hereby alerts consumers to the filing of a talcum powder class action lawsuit that has been filed against Johnson & Johnson. The lawsuit alleges that using this product can increase the risk of ovarian cancer.
Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK
PR Newswire - Mon Jun 30, 4:20AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ), AbbVie Inc (NYSE: ABBV), Valeant Pharmaceuticals Intl Inc (NYSE: VRX) and GlaxoSmithKline plc (ADR) (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4237-100free.
World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) 2013-2017
M2 - Mon Jun 30, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4h95wb/the_world_market) has announced the addition of the "The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)" report to their offering. The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) Catheters make it possible to drain or inject fluids or enable access to the body by surgical instruments. In most instances, a catheter is a thin, flexible tube, though there is great diversity in catheter types and applications. This report provides descriptions of the types of catheters and estimates their market size and discusses the competitive activity in each category. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. This is a minimally invasive procedure in which a catheter is guided into the heart, usually through a blood vessel in the leg or arm. Once inside the heart, it can be used for diagnosing or treating a condition. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia. The purpose of the drain is to remove fluid or blood from the surgical site. This helps the healing process. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize on the World Market for Catheters. This report is a comprehensive look at the market of these critical medical devices. Which segments of catheters provide the most opportunity? Which are growing the fastest? Who are the key players and what share do they have of the market? What are the critical issues and trends that will drive catheter sales in the future. What pitfalls do manufacturers need to be aware of? These questions and more are answered in this report. This report contains global market size and forecast to 2017 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters Suction Catheters Wound Drainage Catheters Company profiles are included, with profiles of the following companies: - Abbott - Angio Dynamics - Atrium Medical - Bactiguard AB - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Edwards Lifesciences - Greatbatch Medical - Johnson & Johnson - Hansen Medical - Iapyx Medical - Integra LifeSciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St. Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/4h...rld_market
(0)
(0)
